Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18.
Martin MockelAnna SlagmanJörn Ole VollertStefan EbmeyerJan C WiemerJulia SearleEvangelos GiannitsisJohn A KellumAlan MaiselPublished in: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals (2018)
The current study will provide evidence, whether the routine use of PCT in patients with suspected AHF improves outcome.